{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:02:24Z","timestamp":1790971344516,"version":"4.1.0"},"reference-count":63,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:p>OBJECTIVE: This study investigated neonatal S100B levels as a biomarker of prenatal selective serotonin reuptake inhibitor (SSRI) exposure.<\/jats:p>\n                  <jats:p>METHODS: Maternal (delivery; N = 53) and neonatal (cord; N = 52) serum S100B levels were compared between prenatally SSRI-exposed (maternal, N = 36; neonatal, N = 37; duration: 230 \u00b1 71 days) and nonexposed (maternal, N = 17; neonatal, N = 15) groups. Measures of maternal depression and anxiety symptoms were assessed during the third trimester (33\u201336 weeks), and neonatal outcomes, including Apgar scores, birth weight, gestational age at birth, and symptoms of poor neonatal adaptation, were recorded.<\/jats:p>\n                  <jats:p>RESULTS: S100B levels were significantly lower in prenatally SSRI-exposed neonates than in nonexposed neonates, controlling for gestational age and third-trimester maternal mood (P = .036). In contrast, SSRI-exposed mothers had significantly higher maternal serum S100B levels, compared with nonexposed mothers (P = .014), even controlling for maternal mood in the third trimester. S100B levels were not associated with maternal or neonatal drug levels, duration of prenatal exposure, demographic variables, or risk for poor neonatal adaptation.<\/jats:p>\n                  <jats:p>CONCLUSIONS: Prenatal SSRI exposure was associated with decreased neonatal serum S100B levels, controlling for prenatal maternal mood. Neonatal S100B levels did not reflect neonatal behavioral outcomes and were not related to pharmacologic indices. These findings are consistent with prenatal alcohol and cocaine exposures, which also alter central serotonin levels.<\/jats:p>","DOI":"10.1542\/peds.2009-0442","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T07:32:40Z","timestamp":1254123160000},"page":"e662-e670","source":"Crossref","is-referenced-by-count":50,"title":["Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors"],"prefix":"10.1542","volume":"124","author":[{"given":"Jodi L.","family":"Pawluski","sequence":"first","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa A.M.","family":"Galea","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Psychology, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Brain","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Papsdorf","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim F.","family":"Oberlander","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"BC Children's Hospital, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"2021120905055237000_R1","doi-asserted-by":"crossref","unstructured":"Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry.\u20082006;63(8):898\u2013906","DOI":"10.1001\/archpsyc.63.8.898"},{"key":"2021120905055237000_R2","doi-asserted-by":"crossref","unstructured":"Huizink AC, Mulder EJ, Buitelaar JK. Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility?Psychol Bull.\u20082004;130(1):115\u2013142","DOI":"10.1037\/0033-2909.130.1.115"},{"key":"2021120905055237000_R3","doi-asserted-by":"crossref","unstructured":"Oberlander TF, Grunau RE, Fitzgerald C, Papsdorf M, Rurak D, Riggs W. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics.\u20082005;115(2):411\u2013425","DOI":"10.1542\/peds.2004-0420"},{"key":"2021120905055237000_R4","doi-asserted-by":"crossref","unstructured":"Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics.\u20082004;113(2):368\u2013375","DOI":"10.1542\/peds.113.2.368"},{"key":"2021120905055237000_R5","doi-asserted-by":"crossref","unstructured":"Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA.\u20082005;293(19):2372\u20132383","DOI":"10.1001\/jama.293.19.2372"},{"key":"2021120905055237000_R6","doi-asserted-by":"crossref","unstructured":"Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med.\u20082007;356(26):2684\u20132692","DOI":"10.1056\/NEJMoa066584"},{"key":"2021120905055237000_R7","doi-asserted-by":"crossref","unstructured":"Wogelius P, Norgaard M, Gislum M, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology.\u20082006;17(6):701\u2013704","DOI":"10.1097\/01.ede.0000239581.76793.ae"},{"key":"2021120905055237000_R8","doi-asserted-by":"crossref","unstructured":"Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med.\u20082006;354(6):579\u2013587","DOI":"10.1056\/NEJMoa052744"},{"key":"2021120905055237000_R9","doi-asserted-by":"crossref","unstructured":"Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry.\u20082003;60(7):720\u2013726","DOI":"10.1001\/archpsyc.60.7.720"},{"key":"2021120905055237000_R10","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia PM. Serotonin and brain development: role in human developmental diseases. Brain Res Bull.\u20082001;56(5):479\u2013485","DOI":"10.1016\/S0361-9230(01)00615-3"},{"key":"2021120905055237000_R11","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia PM. Role of the neurotrophic properties of serotonin in the delay of brain maturation induced by cocaine. Ann N Y Acad Sci.\u20081998;846:158\u2013164","DOI":"10.1111\/j.1749-6632.1998.tb09734.x"},{"key":"2021120905055237000_R12","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia PM, Azmitia EC. Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons. Brain Res.\u20081989;497(1):80\u201385","DOI":"10.1016\/0006-8993(89)90972-4"},{"key":"2021120905055237000_R13","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia PM, Murphy R, Azmitia EC. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth-factor, protein S-100, and alters astroglial morphology. Brain Res.\u20081990;528(1):155\u2013158","DOI":"10.1016\/0006-8993(90)90210-3"},{"key":"2021120905055237000_R14","doi-asserted-by":"crossref","unstructured":"Ramos AJ, Rubio MD, Defagot C, Hischberg L, Villar MJ, Brusco A. The 5-HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Brain Res.\u20082004;1030(2):201\u2013220","DOI":"10.1016\/j.brainres.2004.10.019"},{"key":"2021120905055237000_R15","doi-asserted-by":"crossref","unstructured":"Azmitia EC, Dolan K, Whitakerazmitia PM. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth-factor. Brain Res.\u20081990;516(2):354\u2013356","DOI":"10.1016\/0006-8993(90)90942-5"},{"key":"2021120905055237000_R16","doi-asserted-by":"crossref","unstructured":"Haring JH, Hagan A, Olson J, Rodgers B. Hippocampal serotonin levels influence the expression of S100\u03b2 detected by immunocytochemistry. Brain Res.\u20081993;631(1):119\u2013123","DOI":"10.1016\/0006-8993(93)91195-X"},{"key":"2021120905055237000_R17","doi-asserted-by":"crossref","unstructured":"Gonzalez-Martinez T, Perez-Pinera P, az-Esnal B, Vega JA. S-100 proteins in the human peripheral nervous system. Microsc Res Tech.\u20082003;60(6):633\u2013638","DOI":"10.1002\/jemt.10304"},{"key":"2021120905055237000_R18","doi-asserted-by":"crossref","unstructured":"Winningham-Major F, Staecker JL, Barger SW, Coats S, Vaneldik LJ. Neurite extension and neuronal survival activities of recombinant S100\u03b2 proteins that differ in the content and position of cysteine residues. J Cell Biol.\u20081989;109(6):3063\u20133071","DOI":"10.1083\/jcb.109.6.3063"},{"key":"2021120905055237000_R19","doi-asserted-by":"crossref","unstructured":"Bhattacharyya A, Oppenheim RW, Prevette D, Moore BW, Brackenbury R, Ratner N. S100 is present in developing chicken neurons and Schwann cells and promotes motor-neuron survival in vivo. J Neurobiol.\u20081992;23(4):451\u2013466","DOI":"10.1002\/neu.480230410"},{"key":"2021120905055237000_R20","doi-asserted-by":"crossref","unstructured":"Selinfreund RH, Barger SW, Pledger WJ, Van Eldik LJ. Neurotrophic protein S100\u03b2 stimulates glial cell proliferation. Proc Natl Acad Sci U S A.\u20081991;88(9):3554\u20133558","DOI":"10.1073\/pnas.88.9.3554"},{"key":"2021120905055237000_R21","doi-asserted-by":"crossref","unstructured":"Brewton LS, Haddad L, Azmitia EC. Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures is rapidly reversed by applied S-100\u03b2. Brain Res.\u20082001;912(1):9\u201316","DOI":"10.1016\/S0006-8993(01)02519-7"},{"key":"2021120905055237000_R22","doi-asserted-by":"crossref","unstructured":"Fano\u0300 G, Mariggio\u0300 MA, Angelella P, et al. The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience.\u20081993;53(4):919\u2013925","DOI":"10.1016\/0306-4522(93)90477-W"},{"key":"2021120905055237000_R23","doi-asserted-by":"crossref","unstructured":"Tort ABL, Portela LV, Tavares MD, et al. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis. Life Sci.\u20082004;76(4):379\u2013384","DOI":"10.1016\/j.lfs.2004.09.003"},{"key":"2021120905055237000_R24","doi-asserted-by":"crossref","unstructured":"Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin Chem.\u20082002;48(12):2097\u20132104","DOI":"10.1093\/clinchem\/48.12.2097"},{"key":"2021120905055237000_R25","doi-asserted-by":"crossref","unstructured":"Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma.\u20082007;24(12):1793\u20131801","DOI":"10.1089\/neu.2007.0316"},{"key":"2021120905055237000_R26","doi-asserted-by":"crossref","unstructured":"Gazzolo D, Vinesi P, Marinoni E, et al. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem.\u20082000;46(7):998\u20131000","DOI":"10.1093\/clinchem\/46.7.998"},{"key":"2021120905055237000_R27","doi-asserted-by":"crossref","unstructured":"Gazzolo D, Lituania M, Bruschettini M, et al. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem.\u20082005;38(3):229\u2013233","DOI":"10.1016\/j.clinbiochem.2004.12.006"},{"key":"2021120905055237000_R28","doi-asserted-by":"crossref","unstructured":"Netto CB, Siqueira IR, Fochesatto C, et al. S100B content and SOD activity in amniotic fluid of pregnancies with Down syndrome. Clin Biochem.\u20082004;37(2):134\u2013137","DOI":"10.1016\/j.clinbiochem.2003.09.010"},{"key":"2021120905055237000_R29","doi-asserted-by":"crossref","unstructured":"Yang YH, Nam MS, Yang ES. Rapid prenatal diagnosis of trisomy 21 by real-time quantitative polymerase chain reaction with amplification of small tandem repeats and S100B in chromosome 21. Yonsei Med J.\u20082005;46(2):193\u2013197","DOI":"10.3349\/ymj.2005.46.2.193"},{"key":"2021120905055237000_R30","doi-asserted-by":"crossref","unstructured":"Bruschettini M, van den Hove DLA, Gazzolo D, Bruschettini P, Blanco CE, Steinbusch HWM. A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat. Brain Res Dev Brain Res.\u20082005;159(2):113\u2013118","DOI":"10.1016\/j.devbrainres.2005.07.003"},{"key":"2021120905055237000_R31","doi-asserted-by":"crossref","unstructured":"Eriksen JL, Gillespie RA, Druse MJ. Effects of in utero ethanol exposure and maternal treatment with a 5-HT1A agonist on S100B-containing glial cells. Brain Res Dev Brain Res.\u20082000;121(2):133\u2013143","DOI":"10.1016\/S0165-3806(00)00029-8"},{"key":"2021120905055237000_R32","doi-asserted-by":"crossref","unstructured":"Zhou FC, Sari Y, Zhang JK, Goodlett CR, Li T. Prenatal alcohol exposure retards the migration and development of serotonin neurons in fetal C57BL mice. Brain Res Dev Brain Res.\u20082001;126(2):147\u2013155","DOI":"10.1016\/S0165-3806(00)00144-9"},{"key":"2021120905055237000_R33","doi-asserted-by":"crossref","unstructured":"Akbari HM, Whitaker-Azmitia PM, Azmitia EC. Prenatal cocaine decreases the trophic factor S-100\u03b2 and induced microcephaly: reversal by postnatal 5-HT1A receptor agonist. Neurosci Lett.\u20081994;170(1):141\u2013144","DOI":"10.1016\/0304-3940(94)90259-3"},{"key":"2021120905055237000_R34","doi-asserted-by":"crossref","unstructured":"Clarke C, Clarke K, Muneyyirci J, Azmitia E, Whitakerazmitia PM. Prenatal cocaine delays astroglial maturation: immunodensitometry shows increased markers of immaturity (vimentin and GAP-43) and decreased proliferation and production of the growth factor S-100. Brain Res Dev Brain Res.\u20081996;91(2):268\u2013273","DOI":"10.1016\/0165-3806(95)00192-1"},{"key":"2021120905055237000_R35","doi-asserted-by":"crossref","unstructured":"Van den Hove DL, Steinbusch HW, Bruschettini M, et al. Prenatal stress reduces S100B in the neonatal rat hippocampus. Neuroreport.\u20082006;17(10):1077\u20131080","DOI":"10.1097\/01.wnr.0000223391.74575.c9"},{"key":"2021120905055237000_R36","doi-asserted-by":"crossref","unstructured":"Gazzolo D, Kornacka M, Bruschettini M, et al. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem.\u20082003;49(7):1215\u20131218","DOI":"10.1373\/49.7.1215"},{"key":"2021120905055237000_R37","doi-asserted-by":"crossref","unstructured":"Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry.\u20081998;44(3):151\u2013162","DOI":"10.1016\/S0006-3223(98)00139-5"},{"key":"2021120905055237000_R38","doi-asserted-by":"crossref","unstructured":"Lesch KP. Linking emotion to the social brain: the role of the serotonin transporter in human social behaviour. EMBO Rep.\u20082007;8(suppl 1):S24\u2013S29","DOI":"10.1038\/sj.embor.7401008"},{"key":"2021120905055237000_R39","doi-asserted-by":"crossref","unstructured":"Hellendall RP, Schambra UB, Liu JP, Lauder JM. Prenatal expression of 5-HT1C and 5-HT2 receptors in the rat central nervous system. Exp Neurol.\u20081993;120(2):186\u2013201","DOI":"10.1006\/exnr.1993.1054"},{"key":"2021120905055237000_R40","doi-asserted-by":"crossref","unstructured":"Robbins TW, Granon S, Muir JL, Durantou F, Harrison A, Everitt BJ. Neural systems underlying arousal and attention. Ann N Y Acad Sci.\u20081998;846:222\u2013237","DOI":"10.1111\/j.1749-6632.1998.tb09740.x"},{"key":"2021120905055237000_R41","doi-asserted-by":"crossref","unstructured":"Curtius HC, Niederwieser A, Viscontini M, et al. Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol.\u20081981;133:277\u2013291","DOI":"10.1007\/978-1-4684-3860-4_16"},{"key":"2021120905055237000_R42","doi-asserted-by":"crossref","unstructured":"Nielsen JB, Lou HC, Andresen J. Biochemical and clinical effects of tyrosine and tryptophan in the Rett syndrome. Brain Dev.\u20081990;12(1):143\u2013147","DOI":"10.1016\/S0387-7604(12)80197-5"},{"key":"2021120905055237000_R43","doi-asserted-by":"crossref","unstructured":"Becker LE. Synaptic dysgenesis. Can J Neurol Sci.\u20081991;18(2):170\u2013180","DOI":"10.1017\/S0317167100031644"},{"key":"2021120905055237000_R44","doi-asserted-by":"crossref","unstructured":"Azmitia EC. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology.\u20081999;21(2 suppl):33S\u201345S","DOI":"10.1016\/S0893-133X(99)00022-6"},{"key":"2021120905055237000_R45","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia PM, Druse M, Walker P, Lauder JM. Serotonin as a developmental signal. Behav Brain Res.\u20081996;73(1\u20132):19\u201329","DOI":"10.1016\/0166-4328(96)00071-X"},{"key":"2021120905055237000_R46","doi-asserted-by":"crossref","unstructured":"Huether G, Thomke F, Adler L. Administration of tryptophan-enriched diets to pregnant rats retards the development of the serotonergic system in their offspring. Brain Res Dev Brain Res.\u20081992;68(2):175\u2013181","DOI":"10.1016\/0165-3806(92)90059-6"},{"key":"2021120905055237000_R47","doi-asserted-by":"crossref","unstructured":"Di Pino G, Moessner R, Lesch KP, Lauder JM, Persico AM. Roles for serotonin in neurodevelopment: more than just neural transmission. Curr Neuropharmacol.\u20082004;2(4):403\u2013417","DOI":"10.2174\/1570159043359495"},{"key":"2021120905055237000_R48","doi-asserted-by":"crossref","unstructured":"Seeman P, Bzowej NH, Guan HC, et al. Human brain dopamine receptors in children and aging adults. Synapse.\u20081987;1(5):399\u2013404","DOI":"10.1002\/syn.890010503"},{"key":"2021120905055237000_R49","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia PM. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev.\u20081991;43(4):553\u2013561","DOI":"10.1007\/978-3-0348-7259-1_5"},{"key":"2021120905055237000_R50","doi-asserted-by":"crossref","unstructured":"Miller JC, Friedhoff AJ. Development of specificity and stereoselectivity of rat brain dopamine receptors. Int J Dev Neurosci.\u20081986;4(1):21\u201326","DOI":"10.1016\/0736-5748(86)90012-2"},{"key":"2021120905055237000_R51","doi-asserted-by":"crossref","unstructured":"Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry.\u20082008;13(1):65\u201373","DOI":"10.1038\/sj.mp.4002007"},{"key":"2021120905055237000_R52","doi-asserted-by":"crossref","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry.\u20081960;23(1):56\u201362","DOI":"10.1136\/jnnp.23.1.56"},{"key":"2021120905055237000_R53","doi-asserted-by":"crossref","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol.\u20081959;32(1):50\u201355","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"2021120905055237000_R54","doi-asserted-by":"crossref","unstructured":"Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry.\u20081987;150(6):782\u2013786","DOI":"10.1192\/bjp.150.6.782"},{"key":"2021120905055237000_R55","doi-asserted-by":"crossref","unstructured":"Tramontina AC, Tramontina F, Bobermin LD, et al. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry.\u20082008;32(6):1580\u20131583","DOI":"10.1016\/j.pnpbp.2008.06.001"},{"key":"2021120905055237000_R56","doi-asserted-by":"crossref","unstructured":"Oberlander TF, Reebye P, Misri S, Papsdorf M, Kim J, Grunau R. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med.\u20082007;161(1):22\u201329","DOI":"10.1001\/archpedi.161.1.22"},{"key":"2021120905055237000_R57","doi-asserted-by":"crossref","unstructured":"Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry.\u20082008;192(5):338\u2013343","DOI":"10.1192\/bjp.bp.107.037101"},{"key":"2021120905055237000_R58","doi-asserted-by":"crossref","unstructured":"Gentile S. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf.\u20082007;30(2):107\u2013121","DOI":"10.2165\/00002018-200730020-00002"},{"key":"2021120905055237000_R59","doi-asserted-by":"crossref","unstructured":"Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J Clin Psychiatry.\u20082008;69(4):666\u2013673","DOI":"10.4088\/JCP.v69n0421"},{"key":"2021120905055237000_R60","doi-asserted-by":"crossref","unstructured":"Schroeter ML, bdul-Khaliq H, Diefenbacher A, Blasig IE. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport.\u20082002;13(13):1675\u20131678","DOI":"10.1097\/00001756-200209160-00021"},{"key":"2021120905055237000_R61","doi-asserted-by":"crossref","unstructured":"Schroeter ML, bdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. Serum markers support disease-specific glial pathology in major depression. J Affect Disord.\u20082008;111(2\u20133):271\u2013280","DOI":"10.1016\/j.jad.2008.03.005"},{"key":"2021120905055237000_R62","doi-asserted-by":"crossref","unstructured":"Hetzel G, Moeller O, Evers S, et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology (Berl).\u20082005;178(2\u20133):161\u2013166","DOI":"10.1007\/s00213-004-1999-z"},{"key":"2021120905055237000_R63","doi-asserted-by":"crossref","unstructured":"Arts B, Peters M, Ponds R, Honig A, Menheere P, van Os J. S100 and impact of ECT on depression and cognition. J ECT.\u20082006;22(3):206\u2013212","DOI":"10.1097\/01.yct.0000235925.37494.2c"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/4\/e662\/1011643\/zpe0100900e662.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/4\/e662\/1011643\/zpe0100900e662.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T17:20:07Z","timestamp":1639070407000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/124\/4\/e662\/71837\/Neonatal-S100B-Protein-Levels-After-Prenatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,10,1]]},"published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2009-0442","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}